Generic Name |
||
---|---|---|
IND |
BAY80-6946 | |
Brand Name (US) |
||
Manufacturer |
Bayer | |
Drug Type |
||
Delivery |
Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
Oncogenic Signal Path Based | |
Strategy |
Block related tumor signal paths | |
Drug Category |
PI3K inhibitor |
Links |
|
Trials of this drug |
|
Trial results |